|

BCG for Therapeutic Use Clinical Trials

1 actively recruiting trial

No change since May 2026

Also known as: BCG

Pipeline

Phase 3: 1

Top Sponsors

  • Chengdu CoenBiotech Co., Ltd1

Indications

  • Non-Muscle Invasive Bladder Cancer1
  • Cancer1

Other1 trial

Clinical Trial for Evaluating the Efficacy and Safety of BCG for Therapeutic Use in the Prevention of Postoperative Recurrence of Medium/High-risk Non-muscle Invasive Bladder Cancer (NMIBC)
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.